A tetrasubstituted GHRH(1-29) analog bearing a Drug Affinity Complex, which binds serum albumin and dramatically extends circulating half-life versus the no-DAC form.
A pentapeptide growth-hormone secretagogue noted in the literature for its selectivity — minimal cross-activity at cortisol and prolactin pathways compared to earlier GHRPs.
A 44-amino-acid GHRH analog stabilised against enzymatic degradation. The most clinically characterised growth hormone releasing hormone in research use.
CJC-1295 with DAC, ipamorelin and tesamorelin: two GHRH analogues and one ghrelin mimetic, acting on the two receptors that set the size of a growth-hormone pulse. Every product page lists the compound's specifications, storage conditions, stability notes derived from its sequence, verified references with a one-line summary of each, and the third-party certificate for the lot in stock where one exists. For how the members of this group compare, read the Growth hormone secretagogue comparison.
Identity data for every compound is on the peptide reference table; how to read a certificate is on the certificate guide.